Now with a better view of how the medication is affecting behavior, packaged-food companies are trying to profit off of the ...

While the food industry has never met a diet trend it didn't seek to capitalize on, GLP-1s at one point seemed to present an ...

A new study published in the scientific journal Nature Communications shows that the inflammatory protein IL-1β has an ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

Ozempic and Mounjaro, used to treat diabetes, and their respective counterparts for weight loss, Wegovy and Zepbound, were approved by the Food and Drug ... but shortages of Novo Nordisk’s ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

Hundreds of Americans have jumped on a multi-state lawsuit alleging that the makers of Ozempic and Mounjaro caused ...

This new insulin might mean fewer injections and better blood sugar control — both up and down — for diabetes patients.

Calley and Casey Means have gotten the attention of conservative media with their views of a flawed health care system.

The United Kingdom is trying to kill two birds with one stone. British Health Secretary Wes Streeting has blamed ‘widening waistbands’ for adding to the pressure on the National Health Service (NHS).

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" ...

LONDON (Reuters) – Britain will study whether the use of Eli Lilly’s weight loss drug can get people back into work and help ...